NDC 54771-2155-1 - Draxxin KP
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54771-2155
- Requested NDC
- 54771-2155-1
- Package NDCs from labels
- 54771-2155-1, 54771-2155-2, 54771-2155-3, 54771-2155-4
- Manufacturer
- Zoetis Inc.
- Effective date
- 2026-04-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| tulathromycin and ketoprofen injection - Zoetis Inc. | Zoetis Inc. | 2026-04-06 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54771-2155-1 | Draxxin KP | 50 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 50 | 7 | |
| 54771-2155-2 | Draxxin KP | 100 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 100 | 7 | |
| 54771-2155-3 | Draxxin KP | 250 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 250 | 7 | |
| 54771-2155-4 | Draxxin KP | 500 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 500 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54771-2155 | DRAXXIN KP (TULATHROMYCIN AND KETOPROFEN INJECTION) INJECTION, SOLUTION [ZOETIS INC.] | 4 | 4 package rows | 20250524_044385d5-c9eb-4a44-9ffd-2b68092262fe.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ketoprofen | KETOPROFEN | Marnel Pharmaceuticals, Inc. | 4e7bceb6-dcb5-c5e0-e063-6294a90a101e | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | 90Y4QC304K |
| Ketoprofen | KETOPROFEN | Oncora Pharma, LLC | 492de5dc-7c1b-47be-8510-43be4e1fd4ed | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | 90Y4QC304K |
| Ketoprofen | KETOPROFEN | Misemer Pharmaceuticals, Inc. | d0f47ab6-29ff-df07-e053-2a95a90a2b51 | 2026-02-15 | Boxed warning, Warnings, Adverse reactions | 90Y4QC304K |
| Orudis | KETOPROFEN | Allegis Pharmaceuticals, Inc. | 47d0b808-7142-c7a9-e063-6394a90a6e0d | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 90Y4QC304K |
| Ketoprofen | KETOPROFEN | Mylan Pharmaceuticals Inc. | 198a4140-f4c0-4478-9157-ee1d68d0bb96 | 2024-07-15 | Boxed warning, Warnings, Adverse reactions | 90Y4QC304K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.